VI
PEARW

Vestcor Inc’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Vestcor Inc’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,333
Closed – – 1254
2023
Q1 		$0 Hold
8,333
– – ﹤0.01% 1324
2022
Q4 		$1K Hold
8,333
– – ﹤0.01% 1256
2022
Q3 		$1K Hold
8,333
– – ﹤0.01% 1342
2022
Q2 		$1K Hold
8,333
– – ﹤0.01% 1337
2022
Q1 		$7K Hold
8,333
– – ﹤0.01% 1356
2021
Q4 		$5K Hold
8,333
– – ﹤0.01% 1386
2021
Q3 		$8K Hold
8,333
– – ﹤0.01% 1252
2021
Q2 		$12K Hold
8,333
– – ﹤0.01% 1255
2021
Q1 		$8K Buy
+8,333
New +$8.13K ﹤0.01% 1133

Other funds holding PEARW

AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Vestcor Inc's PEARW Position: Q2 2023 in Review

Vestcor Inc sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 8,333 shares.

Vestcor Inc first reported a position in PEARW in Q1 2021 and held it in 9 quarters. The position peaked at $12K in Q2 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

  • Vestcor Inc reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
  • Vestcor Inc sold 8,333 Pear Therapeutics, Inc. Warrant shares in Q2 2023.
  • Vestcor Inc first reported a position in Pear Therapeutics, Inc. Warrant in Q1 2021 and held it in 9 quarters.
  • Vestcor Inc's Pear Therapeutics, Inc. Warrant position peaked at $12K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Vestcor Inc's 13F filing for Q2 2023, filed 15 Aug 2023.